{
  "company": {
    "name": "Adela",
    "website": "https://adelabio.com/",
    "record": "https://startuphistory.org/c/adelabio.com"
  },
  "status": null,
  "history_since": "2021-06-23T12:00:09.000Z",
  "baseline": {
    "snapshot_id": "a9d63a235b0eddb5d4f3075459cccba31177d9b1c21d20247548c6ae8d1f0e08",
    "observed_at": "2021-06-23T12:00:09.000Z",
    "headline": null,
    "description": "Adela is focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test.",
    "evidence": "https://web.archive.org/web/20210623120009/https://www.adelabio.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-04T09:40:43.458Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2026-04-16T17:47:40.000Z",
      "variants": [
        {
          "headline": "ADELA | A breakthrough approach to early detection",
          "subhead": "Adela is focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test.",
          "observed_at": "2022-01-11T10:57:30.000Z",
          "evidence": "https://web.archive.org/web/20220111105730/https://www.adelabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "ADELA | A breakthrough approach to early detection",
          "subhead": "Adela is focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test.",
          "observed_at": "2023-01-29T23:16:50.000Z",
          "evidence": "https://web.archive.org/web/20230129231650/https://www.adelabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "ADELA | A breakthrough approach to early detection",
          "subhead": "Adela is focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test.",
          "observed_at": "2023-09-26T10:21:54.000Z",
          "evidence": "https://web.archive.org/web/20230926102154/https://www.adelabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "ADELA | A breakthrough approach to early detection",
          "subhead": "Adela is focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test.",
          "observed_at": "2024-01-26T11:48:52.000Z",
          "evidence": "https://web.archive.org/web/20240126114852/https://www.adelabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "A breakthrough approach to cancer detection",
          "subhead": "Adela is developing best-in-class technology to accelerate the diagnosis and improve the management of cancer through blood tests. With a single, scalable platform, Adela can address the unmet need br",
          "observed_at": "2024-09-01T10:31:01.000Z",
          "evidence": "https://web.archive.org/web/20240901103101/https://www.adelabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "A breakthrough approach to cancer detection",
          "subhead": "Adela is developing best-in-class technology to accelerate the diagnosis and improve the management of cancer through blood tests. With a single, scalable platform, Adela can address the unmet need br",
          "observed_at": "2025-07-24T19:53:49.000Z",
          "evidence": "https://web.archive.org/web/20250724195349/https://www.adelabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "A breakthrough approach to cancer detection",
          "subhead": "Adela is developing best-in-class technology to accelerate the diagnosis and improve the management of cancer through blood tests. With a single, scalable platform, Adela can address the unmet need br",
          "observed_at": "2026-01-17T07:56:34.000Z",
          "evidence": "https://web.archive.org/web/20260117075634/https://www.adelabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "A breakthrough approach to cancer detection",
          "subhead": "Adela is developing best-in-class technology to accelerate the diagnosis and improve the management of cancer through blood tests. With a single, scalable platform, Adela can address the unmet need br",
          "observed_at": "2026-04-16T17:47:40.000Z",
          "evidence": "https://web.archive.org/web/20260416174740/https://www.adelabio.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "A breakthrough approach to cancer detection",
      "subhead": "Adela is developing best-in-class technology to accelerate the diagnosis and improve the management of cancer through blood tests. With a single, scalable platform, Adela can address the unmet need br",
      "from": "2022-01-11T10:57:30.000Z",
      "to": "2026-04-16T17:47:40.000Z",
      "captures": 8,
      "evidence": "https://web.archive.org/web/20260416174740/https://www.adelabio.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2022-01-11T10:57:30.000Z",
          "to": "2026-04-16T17:47:40.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-04T09:40:43.458Z",
      "variants": [
        {
          "headline": "Best-in-class technology. Tissue-free detection.",
          "subhead": "Adela is developing best-in-class technology to accelerate the diagnosis and improve the management of cancer through blood tests. With a single, scalable platform, Adela can address the unmet need br",
          "observed_at": "2026-07-16T02:15:42.000Z",
          "evidence": "https://web.archive.org/web/20260716021542/https://www.adelabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Best-in-class technology. Tissue-free detection.",
          "subhead": "Adela is developing best-in-class technology to accelerate the diagnosis and improve the management of cancer through blood tests. With a single, scalable platform, Adela can address the unmet need br",
          "observed_at": "2026-10-12T13:34:59.000Z",
          "evidence": "https://web.archive.org/web/20261012133459/https://www.adelabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Best-in-class technology. Tissue-free detection.",
          "subhead": "Adela is developing best-in-class technology to accelerate the diagnosis and improve the management of cancer through blood tests. With a single, scalable platform, Adela can address the unmet need br",
          "observed_at": "2026-11-04T09:40:43.458Z",
          "evidence": "https://www.adelabio.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Best-in-class technology. Tissue-free detection.",
      "subhead": "Adela is developing best-in-class technology to accelerate the diagnosis and improve the management of cancer through blood tests. With a single, scalable platform, Adela can address the unmet need br",
      "from": "2026-07-16T02:15:42.000Z",
      "to": "2026-11-04T09:40:43.458Z",
      "captures": 3,
      "evidence": "https://www.adelabio.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2026-07-16T02:15:42.000Z",
          "to": "2026-11-04T09:40:43.458Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-f68f0c6cff84d480b5d49f74d86b6899a78694099ef87c50bc941cd835634c4d:47fa728dc18ad1c72334ff5900aa95665bf2e2cb5ad51d79e5660cae6bc019ac:headline:f291c87e5573e3dd",
      "before_evidence": "https://web.archive.org/web/20260416174740/https://www.adelabio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “A breakthrough approach to cancer detection” to “Best-in-class technology. Tissue-free detection.”.",
      "between": {
        "from": "2026-04-16T17:47:40.000Z",
        "to": "2026-07-16T02:15:42.000Z"
      },
      "evidence": "https://web.archive.org/web/20260716021542/https://www.adelabio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Adela” company record, https://startuphistory.org/c/adelabio.com"
}